Adults with obesity receiving tirzepatide 10 mg or 15 mg may be able to maintain most of their weight loss after switching to ...

Oral orforglipron helped adults maintain clinically meaningful weight loss after prior injectable tirzepatide or semaglutide ...

Two phase 3b trials evaluated the efficacy and safety of tirzepatide or orforglipron for weight maintenance after injectable incretin treatment.

Eli Lilly and Novo Nordisk are building cases for their incretin drugs both new and old as attractive weight loss maintenance ...

New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) and published in Nature ...

A new daily pill could help people coming off weight-loss jabs remain slim, latest research says. The drug is already ...

New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12–15 May) and published in The Lancet shows that people who have lost weight using the maximum tolerated ...

Effectiveness and toxicity of multidisciplinary treatment of head and neck cancer among people with HIV: Real-world evidence from a tertiary cancer center in Brazil. This is an ASCO Meeting Abstract ...

Novo Nordisk has identified a group of early responders to its high-dose Wegovy formulation that shed almost 28% of their ...

The FDA has proposed excluding weight-loss drugs, such as Ozempic/Wegovy and Zepbound from a key compounding list, ...

India has become one of the first countries to introduce cheaper, generic brands of weight loss drugs like Ozempic and Wegovy ...